Now you gotta see what antacid you use. There are different kind of antacids and while they all seems the same to you but there are different compositions to each antacid.Antacids with proton pump...
The U.S. litigation regarding Pradaxa has been settled for the hefty amount of $650 million. The fact was ceded by Boehringer Ingelheim. Pradaxa stands for dabigatran etexilate mesylate. The...
The FDA’s Cardiovascular and Renal Drugs Advisory Committee voted 10-1 in favor of approval for vorapaxar, Merck's novel thrombin receptor antagonist. The “roller coaster ride” cliché might have...
A few years ago a novel antiplatelet agent from Merck seemed all but dead. Vorapaxar, a thrombin receptor antagonist, was widely thought to have no future after unacceptably high serious bleeding...